MVP anticorps (AA 158-350)
Aperçu rapide pour MVP anticorps (AA 158-350) (ABIN1886076)
Antigène
Voir toutes MVP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 158-350
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 158 and 350 of LRP(MVP)
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- MVP (Major Vault Protein (MVP))
-
Autre désignation
- LRP(MVP)
-
Sujet
-
This gene encodes the major vault protein which is a lung resistance-related protein.Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport.This protein mediates drug resistance, perhaps via a transport process.It is widely distributed in normal tissues, and overexpressed in multidrug-resistant cancer cells.The protein overexpression is a potentially useful marker of clinical drug resistance.This gene produces two transcripts by using two alternative exon 2 sequences, however, the open reading frames are the same in both transcripts.[provided by RefSeq]
-
Poids moléculaire
- 99 kDa
-
ID gène
- 9961
Antigène
-